Understanding the US Programme for Bioresearch Monitoring
This article was originally published in SRA
Executive Summary
Following the pledge by the Food and Drug Administration to step up efforts regarding its programme for ensuring the validity of the scientific data used to support product approval applications, Mark Elengold describes the ins and outs of the system.